Table of Contents 1 Human Recombinant Insulin Market Overview 1.1 Product Overview and Scope of Human Recombinant Insulin 1.2 Human Recombinant Insulin Segment by Type 1.2.1 Global Human Recombinant Insulin Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Rapid-Acting Human Insulin 1.2.3 Regular (Short Acting) Insulin 1.2.4 NPH (Intermediate Acting) Insulin 1.2.5 Long-Acting Human Insulin 1.2.6 Premixed Human Insulins Insulin 1.3 Human Recombinant Insulin Segment by Application 1.3.1 Human Recombinant Insulin Sales Comparison by Application: 2020 VS 2026 1.3.2 Hospital 1.3.3 Retail Pharmacy 1.3.4 Online Pharmacies 1.3.5 Other 1.4 Global Human Recombinant Insulin Market Size Estimates and Forecasts 1.4.1 Global Human Recombinant Insulin Revenue 2015-2026 1.4.2 Global Human Recombinant Insulin Sales 2015-2026 1.4.3 Human Recombinant Insulin Market Size by Region: 2020 Versus 2026 2 Global Human Recombinant Insulin Market Competition by Manufacturers 2.1 Global Human Recombinant Insulin Sales Market Share by Manufacturers (2015-2020) 2.2 Global Human Recombinant Insulin Revenue Share by Manufacturers (2015-2020) 2.3 Global Human Recombinant Insulin Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Human Recombinant Insulin Manufacturing Sites, Area Served, Product Type 2.5 Human Recombinant Insulin Market Competitive Situation and Trends 2.5.1 Human Recombinant Insulin Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Human Recombinant Insulin Players (Opinion Leaders) 3 Human Recombinant Insulin Retrospective Market Scenario by Region 3.1 Global Human Recombinant Insulin Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Human Recombinant Insulin Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Human Recombinant Insulin Market Facts & Figures by Country 3.3.1 North America Human Recombinant Insulin Sales by Country 3.3.2 North America Human Recombinant Insulin Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Human Recombinant Insulin Market Facts & Figures by Country 3.4.1 Europe Human Recombinant Insulin Sales by Country 3.4.2 Europe Human Recombinant Insulin Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Human Recombinant Insulin Market Facts & Figures by Region 3.5.1 Asia Pacific Human Recombinant Insulin Sales by Region 3.5.2 Asia Pacific Human Recombinant Insulin Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Human Recombinant Insulin Market Facts & Figures by Country 3.6.1 Latin America Human Recombinant Insulin Sales by Country 3.6.2 Latin America Human Recombinant Insulin Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Human Recombinant Insulin Market Facts & Figures by Country 3.7.1 Middle East and Africa Human Recombinant Insulin Sales by Country 3.7.2 Middle East and Africa Human Recombinant Insulin Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Human Recombinant Insulin Historic Market Analysis by Type 4.1 Global Human Recombinant Insulin Sales Market Share by Type (2015-2020) 4.2 Global Human Recombinant Insulin Revenue Market Share by Type (2015-2020) 4.3 Global Human Recombinant Insulin Price Market Share by Type (2015-2020) 4.4 Global Human Recombinant Insulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Human Recombinant Insulin Historic Market Analysis by Application 5.1 Global Human Recombinant Insulin Sales Market Share by Application (2015-2020) 5.2 Global Human Recombinant Insulin Revenue Market Share by Application (2015-2020) 5.3 Global Human Recombinant Insulin Price by Application (2015-2020) 6 Company Profiles and Key Figures in Human Recombinant Insulin Business 6.1 Novo Nordisk 6.1.1 Corporation Information 6.1.2 Novo Nordisk Description, Business Overview and Total Revenue 6.1.3 Novo Nordisk Human Recombinant Insulin Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Novo Nordisk Products Offered 6.1.5 Novo Nordisk Recent Development 6.2 Eli Lilly and Company 6.2.1 Eli Lilly and Company Human Recombinant Insulin Production Sites and Area Served 6.2.2 Eli Lilly and Company Description, Business Overview and Total Revenue 6.2.3 Eli Lilly and Company Human Recombinant Insulin Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Eli Lilly and Company Products Offered 6.2.5 Eli Lilly and Company Recent Development 6.3 Sanofi 6.3.1 Sanofi Human Recombinant Insulin Production Sites and Area Served 6.3.2 Sanofi Description, Business Overview and Total Revenue 6.3.3 Sanofi Human Recombinant Insulin Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Sanofi Products Offered 6.3.5 Sanofi Recent Development 6.4 Julphar Gulf Pharmaceutical Industries 6.4.1 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Production Sites and Area Served 6.4.2 Julphar Gulf Pharmaceutical Industries Description, Business Overview and Total Revenue 6.4.3 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Julphar Gulf Pharmaceutical Industries Products Offered 6.4.5 Julphar Gulf Pharmaceutical Industries Recent Development 6.5 Bioton 6.5.1 Bioton Human Recombinant Insulin Production Sites and Area Served 6.5.2 Bioton Description, Business Overview and Total Revenue 6.5.3 Bioton Human Recombinant Insulin Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Bioton Products Offered 6.5.5 Bioton Recent Development 6.6 Gan & Lee Pharmaceuticals 6.6.1 Gan & Lee Pharmaceuticals Human Recombinant Insulin Production Sites and Area Served 6.6.2 Gan & Lee Pharmaceuticals Description, Business Overview and Total Revenue 6.6.3 Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Gan & Lee Pharmaceuticals Products Offered 6.6.5 Gan & Lee Pharmaceuticals Recent Development 6.7 Zhuhai United Laboratories 6.6.1 Zhuhai United Laboratories Human Recombinant Insulin Production Sites and Area Served 6.6.2 Zhuhai United Laboratories Description, Business Overview and Total Revenue 6.6.3 Zhuhai United Laboratories Human Recombinant Insulin Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Zhuhai United Laboratories Products Offered 6.7.5 Zhuhai United Laboratories Recent Development 6.8 Biocon 6.8.1 Biocon Human Recombinant Insulin Production Sites and Area Served 6.8.2 Biocon Description, Business Overview and Total Revenue 6.8.3 Biocon Human Recombinant Insulin Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Biocon Products Offered 6.8.5 Biocon Recent Development 6.9 Wanbang Biopharmaceuticals 6.9.1 Wanbang Biopharmaceuticals Human Recombinant Insulin Production Sites and Area Served 6.9.2 Wanbang Biopharmaceuticals Description, Business Overview and Total Revenue 6.9.3 Wanbang Biopharmaceuticals Human Recombinant Insulin Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Wanbang Biopharmaceuticals Products Offered 6.9.5 Wanbang Biopharmaceuticals Recent Development 6.10 Dongbao Enterprise Group 6.10.1 Dongbao Enterprise Group Human Recombinant Insulin Production Sites and Area Served 6.10.2 Dongbao Enterprise Group Description, Business Overview and Total Revenue 6.10.3 Dongbao Enterprise Group Human Recombinant Insulin Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Dongbao Enterprise Group Products Offered 6.10.5 Dongbao Enterprise Group Recent Development 6.11 PeproTech 6.11.1 PeproTech Human Recombinant Insulin Production Sites and Area Served 6.11.2 PeproTech Human Recombinant Insulin Description, Business Overview and Total Revenue 6.11.3 PeproTech Human Recombinant Insulin Sales, Revenue and Gross Margin (2015-2020) 6.11.4 PeproTech Products Offered 6.11.5 PeproTech Recent Development 7 Human Recombinant Insulin Manufacturing Cost Analysis 7.1 Human Recombinant Insulin Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Human Recombinant Insulin 7.4 Human Recombinant Insulin Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Human Recombinant Insulin Distributors List 8.3 Human Recombinant Insulin Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Human Recombinant Insulin Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Human Recombinant Insulin by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Human Recombinant Insulin by Type (2021-2026) 10.2 Human Recombinant Insulin Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Human Recombinant Insulin by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Human Recombinant Insulin by Application (2021-2026) 10.3 Human Recombinant Insulin Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Human Recombinant Insulin by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Human Recombinant Insulin by Region (2021-2026) 10.4 North America Human Recombinant Insulin Estimates and Projections (2021-2026) 10.5 Europe Human Recombinant Insulin Estimates and Projections (2021-2026) 10.6 Asia Pacific Human Recombinant Insulin Estimates and Projections (2021-2026) 10.7 Latin America Human Recombinant Insulin Estimates and Projections (2021-2026) 10.8 Middle East and Africa Human Recombinant Insulin Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Human Recombinant Insulin Sales (K Litre) Growth Rate Comparison by Type (2015-2026) Table 2. Global Human Recombinant Insulin Sales (K Litre) Comparison by Application: 2020 VS 2026 Table 3. Global Human Recombinant Insulin Market Size by Type (K Litre) (US$ Million) (2020 VS 2026) Table 4. Global Key Human Recombinant Insulin Manufacturers Covered in This Study Table 5. Global Human Recombinant Insulin Sales (K Litre) by Manufacturers (2015-2020) Table 6. Global Human Recombinant Insulin Sales Share by Manufacturers (2015-2020) Table 7. Global Human Recombinant Insulin Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Human Recombinant Insulin Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Human Recombinant Insulin Average Price (USD/Litre) of Key Manufacturers (2015-2020) Table 10. Manufacturers Human Recombinant Insulin Sales Sites and Area Served Table 11. Manufacturers Human Recombinant Insulin Product Types Table 12. Global Human Recombinant Insulin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Human Recombinant Insulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Recombinant Insulin as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Human Recombinant Insulin Players Table 16. Global Human Recombinant Insulin Sales (K Litre) by Region (2015-2020) Table 17. Global Human Recombinant Insulin Sales Market Share by Region (2015-2020) Table 18. Global Human Recombinant Insulin Revenue (Million US$) by Region (2015-2020) Table 19. Global Human Recombinant Insulin Revenue Market Share by Region (2015-2020) Table 20. North America Human Recombinant Insulin Sales by Country (2015-2020) (K Litre) Table 21. North America Human Recombinant Insulin Sales Market Share by Country (2015-2020) Table 22. North America Human Recombinant Insulin Revenue by Country (2015-2020) (US$ Million) Table 23. North America Human Recombinant Insulin Revenue Market Share by Country (2015-2020) Table 24. Europe Human Recombinant Insulin Sales by Country (2015-2020) (K Litre) Table 25. Europe Human Recombinant Insulin Sales Market Share by Country (2015-2020) Table 26. Europe Human Recombinant Insulin Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Human Recombinant Insulin Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Human Recombinant Insulin Sales by Region (2015-2020) (K Litre) Table 29. Asia Pacific Human Recombinant Insulin Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Human Recombinant Insulin Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Human Recombinant Insulin Revenue Market Share by Region (2015-2020) Table 32. Latin America Human Recombinant Insulin Sales by Country (2015-2020) (K Litre) Table 33. Latin America Human Recombinant Insulin Sales Market Share by Country (2015-2020) Table 34. Latin America Human Recombinant Insulin Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Human Recombinant Insulin Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Human Recombinant Insulin Sales by Country (2015-2020) (K Litre) Table 37. Middle East and Africa Human Recombinant Insulin Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Human Recombinant Insulin Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Human Recombinant Insulin Revenue Market Share by Country (2015-2020) Table 40. Global Human Recombinant Insulin Sales (K Litre) by Type (2015-2020) Table 41. Global Human Recombinant Insulin Sales Share by Type (2015-2020) Table 42. Global Human Recombinant Insulin Revenue (Million US$) by Type (2015-2020) Table 43. Global Human Recombinant Insulin Revenue Share by Type (2015-2020) Table 44. Global Human Recombinant Insulin Price (USD/Litre) by Type (2015-2020) Table 45. Global Human Recombinant Insulin Sales (K Litre) by Application (2015-2020) Table 46. Global Human Recombinant Insulin Sales Market Share by Application (2015-2020) Table 47. Global Human Recombinant Insulin Sales Growth Rate by Application (2015-2020) Table 48. Novo Nordisk Human Recombinant Insulin Corporation Information Table 49. Novo Nordisk Description and Business Overview Table 50. Novo Nordisk Human Recombinant Insulin Sales (K Litre), Revenue (Million US$), Price (USD/Litre) and Gross Margin (2015-2020) Table 51. Novo Nordisk Main Product Table 52. Novo Nordisk Recent Development Table 53. Eli Lilly and Company Human Recombinant Insulin Corporation Information Table 54. Eli Lilly and Company Corporation Information Table 55. Eli Lilly and Company Human Recombinant Insulin Sales (K Litre), Revenue (Million US$), Price (USD/Litre) and Gross Margin (2015-2020) Table 56. Eli Lilly and Company Main Product Table 57. Eli Lilly and Company Recent Development Table 58. Sanofi Human Recombinant Insulin Corporation Information Table 59. Sanofi Corporation Information Table 60. Sanofi Human Recombinant Insulin Sales (K Litre), Revenue (Million US$), Price (USD/Litre) and Gross Margin (2015-2020) Table 61. Sanofi Main Product Table 62. Sanofi Recent Development Table 63. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Corporation Information Table 64. Julphar Gulf Pharmaceutical Industries Corporation Information Table 65. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales (K Litre), Revenue (Million US$), Price (USD/Litre) and Gross Margin (2015-2020) Table 66. Julphar Gulf Pharmaceutical Industries Main Product Table 67. Julphar Gulf Pharmaceutical Industries Recent Development Table 68. Bioton Human Recombinant Insulin Corporation Information Table 69. Bioton Corporation Information Table 70. Bioton Human Recombinant Insulin Sales (K Litre), Revenue (Million US$), Price (USD/Litre) and Gross Margin (2015-2020) Table 71. Bioton Main Product Table 72. Bioton Recent Development Table 73. Gan & Lee Pharmaceuticals Human Recombinant Insulin Corporation Information Table 74. Gan & Lee Pharmaceuticals Corporation Information Table 75. Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales (K Litre), Revenue (Million US$), Price (USD/Litre) and Gross Margin (2015-2020) Table 76. Gan & Lee Pharmaceuticals Main Product Table 77. Gan & Lee Pharmaceuticals Recent Development Table 78. Zhuhai United Laboratories Human Recombinant Insulin Corporation Information Table 79. Zhuhai United Laboratories Corporation Information Table 80. Zhuhai United Laboratories Human Recombinant Insulin Sales (K Litre), Revenue (Million US$), Price (USD/Litre) and Gross Margin (2015-2020) Table 81. Zhuhai United Laboratories Main Product Table 82. Zhuhai United Laboratories Recent Development Table 83. Biocon Human Recombinant Insulin Corporation Information Table 84. Biocon Corporation Information Table 85. Biocon Human Recombinant Insulin Sales (K Litre), Revenue (Million US$), Price (USD/Litre) and Gross Margin (2015-2020) Table 86. Biocon Main Product Table 87. Biocon Recent Development Table 88. Wanbang Biopharmaceuticals Human Recombinant Insulin Corporation Information Table 89. Wanbang Biopharmaceuticals Corporation Information Table 90. Wanbang Biopharmaceuticals Human Recombinant Insulin Sales (K Litre), Revenue (Million US$), Price (USD/Litre) and Gross Margin (2015-2020) Table 91. Wanbang Biopharmaceuticals Main Product Table 92. Wanbang Biopharmaceuticals Recent Development Table 93. Dongbao Enterprise Group Human Recombinant Insulin Corporation Information Table 94. Dongbao Enterprise Group Corporation Information Table 95. Dongbao Enterprise Group Human Recombinant Insulin Sales (K Litre), Revenue (Million US$), Price (USD/Litre) and Gross Margin (2015-2020) Table 96. Dongbao Enterprise Group Main Product Table 97. Dongbao Enterprise Group Recent Development Table 98. PeproTech Human Recombinant Insulin Corporation Information Table 99. PeproTech Corporation Information Table 100. PeproTech Human Recombinant Insulin Sales (K Litre), Revenue (Million US$), Price (USD/Litre) and Gross Margin (2015-2020) Table 101. PeproTech Main Product Table 102. PeproTech Recent Development Table 103. Sales Base and Market Concentration Rate of Raw Material Table 104. Key Suppliers of Raw Materials Table 105. Human Recombinant Insulin Distributors List Table 106. Human Recombinant Insulin Customers List Table 107. Market Key Trends Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 109. Key Challenges Table 110. Global Human Recombinant Insulin Sales (K Litre) Forecast by Type (2021-2026) Table 111. Global Human Recombinant Insulin Sales Market Share Forecast by Type (2021-2026) Table 112. Global Human Recombinant Insulin Revenue (Million US$) Forecast by Type (2021-2026) Table 113. Global Human Recombinant Insulin Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 114. Global Human Recombinant Insulin Sales (K Litre) Forecast by Application (2021-2026) Table 115. Global Human Recombinant Insulin Revenue (Million US$) Forecast by Application (2021-2026) Table 116. Global Human Recombinant Insulin Sales (K Litre) Forecast by Region (2021-2026) Table 117. Global Human Recombinant Insulin Sales Market Share Forecast by Region (2021-2026) Table 118. Global Human Recombinant Insulin Revenue Forecast by Region (2021-2026) (US$ Million) Table 119. Global Human Recombinant Insulin Revenue Market Share Forecast by Region (2021-2026) Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Human Recombinant Insulin Figure 2. Global Human Recombinant Insulin Sales Market Share by Type: 2020 VS 2026 Figure 3. Rapid-Acting Human Insulin Product Picture Figure 4. Regular (Short Acting) Insulin Product Picture Figure 5. NPH (Intermediate Acting) Insulin Product Picture Figure 6. Long-Acting Human Insulin Product Picture Figure 7. Premixed Human Insulins Insulin Product Picture Figure 8. Global Human Recombinant Insulin Consumption Market Share by Application: 2020 VS 2026 Figure 9. Hospital Figure 10. Retail Pharmacy Figure 11. Online Pharmacies Figure 12. Other Figure 13. Global Human Recombinant Insulin Market Size 2015-2026 (US$ Million) Figure 14. Global Human Recombinant Insulin Sales Capacity (K Litre) (2015-2026) Figure 15. Global Human Recombinant Insulin Market Size Market Share by Region: 2020 Versus 2026 Figure 16. Human Recombinant Insulin Sales Share by Manufacturers in 2020 Figure 17. Global Human Recombinant Insulin Revenue Share by Manufacturers in 2019 Figure 18. The Global 5 and 10 Largest Players: Market Share by Human Recombinant Insulin Revenue in 2019 Figure 19. Human Recombinant Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 20. Global Human Recombinant Insulin Sales Market Share by Region (2015-2020) Figure 21. Global Human Recombinant Insulin Sales Market Share by Region in 2019 Figure 22. Global Human Recombinant Insulin Revenue Market Share by Region (2015-2020) Figure 23. Global Human Recombinant Insulin Revenue Market Share by Region in 2019 Figure 24. North America Human Recombinant Insulin Sales Market Share by Country in 2019 Figure 25. North America Human Recombinant Insulin Revenue Market Share by Country in 2019 Figure 26. U.S. Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 27. U.S. Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 28. Canada Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 29. Canada Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 30. Europe Human Recombinant Insulin Sales Market Share by Country in 2019 Figure 31. Europe Human Recombinant Insulin Revenue Market Share by Country in 2019 Figure 32. Germany Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 33. Germany Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. France Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 35. France Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. U.K. Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 37. U.K. Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Italy Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 39. Italy Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Russia Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 41. Russia Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Asia Pacific Human Recombinant Insulin Sales Market Share by Region in 2019 Figure 43. Asia Pacific Human Recombinant Insulin Revenue Market Share by Region in 2019 Figure 44. China Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 45. China Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. Japan Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 47. Japan Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. South Korea Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 49. South Korea Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. India Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 51. India Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Australia Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 53. Australia Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Taiwan Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 55. Taiwan Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Indonesia Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 57. Indonesia Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Thailand Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 59. Thailand Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Malaysia Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 61. Malaysia Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Philippines Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 63. Philippines Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Vietnam Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 65. Vietnam Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Latin America Human Recombinant Insulin Sales Market Share by Country in 2019 Figure 67. Latin America Human Recombinant Insulin Revenue Market Share by Country in 2019 Figure 68. Mexico Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 69. Mexico Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Brazil Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 71. Brazil Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Argentina Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 73. Argentina Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Middle East and Africa Human Recombinant Insulin Sales Market Share by Country in 2019 Figure 75. Middle East and Africa Human Recombinant Insulin Revenue Market Share by Country in 2019 Figure 76. Turkey Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 77. Turkey Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Saudi Arabia Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 79. Saudi Arabia Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. U.A.E Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre) Figure 81. U.A.E Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Sales Market Share of Human Recombinant Insulin by Type (2015-2020) Figure 83. Sales Market Share of Human Recombinant Insulin by Type in 2019 Figure 84. Revenue Share of Human Recombinant Insulin by Type (2015-2020) Figure 85. Revenue Market Share of Human Recombinant Insulin by Type in 2019 Figure 86. Global Human Recombinant Insulin Sales Growth by Type (2015-2020) (K Litre) Figure 87. Global Human Recombinant Insulin Sales Market Share by Application (2015-2020) Figure 88. Global Human Recombinant Insulin Sales Market Share by Application in 2019 Figure 89. Global Revenue Share of Human Recombinant Insulin by Application (2015-2020) Figure 90. Global Revenue Share of Human Recombinant Insulin by Application in 2020 Figure 91. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Julphar Gulf Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Bioton Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Gan & Lee Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Zhuhai United Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Biocon Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Wanbang Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Dongbao Enterprise Group Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. PeproTech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Price Trend of Key Raw Materials Figure 103. Manufacturing Cost Structure of Human Recombinant Insulin Figure 104. Manufacturing Process Analysis of Human Recombinant Insulin Figure 105. Human Recombinant Insulin Industrial Chain Analysis Figure 106. Channels of Distribution Figure 107. Distributors Profiles Figure 108. Porter's Five Forces Analysis Figure 109. North America Human Recombinant Insulin Sales (K Litre) and Growth Rate Forecast (2021-2026) Figure 110. North America Human Recombinant Insulin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Europe Human Recombinant Insulin Sales (K Litre) and Growth Rate Forecast (2021-2026) Figure 112. Europe Human Recombinant Insulin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Latin America Human Recombinant Insulin Sales (K Litre) and Growth Rate Forecast (2021-2026) Figure 114. Latin America Human Recombinant Insulin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Middle East and Africa Human Recombinant Insulin Sales (K Litre) and Growth Rate Forecast (2021-2026) Figure 116. Middle East and Africa Human Recombinant Insulin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 117. Asia Pacific Human Recombinant Insulin Sales (K Litre) and Growth Rate Forecast (2021-2026) Figure 118. Asia Pacific Human Recombinant Insulin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 119. Bottom-up and Top-down Approaches for This Report Figure 120. Data Triangulation Figure 121. Key Executives Interviewed

Novo Nordisk Eli Lilly and Company Sanofi Julphar Gulf Pharmaceutical Industries Bioton Gan & Lee Pharmaceuticals Zhuhai United Laboratories Biocon Wanbang Biopharmaceuticals Dongbao Enterprise Group PeproTech